ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Chengyue Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-9676-0384; OpenAlex author ID A5007989522. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 2 papers

Papers 2

Nanoadjuvant-Mediated Electro-Immunotherapy Enhances Irreversible Electroporation for Pancreatic Cancer Treatment. Co-author DOI 10.1002/adma.202520546 ↗
High-voltage electrical pulses for pancreatic cancer treatment in the era of precision medicine. Co-author DOI 10.1097/js9.0000000000003386 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tianan Jiang · 2 shared papers, 2026 · strength 0.57
- Paper High-voltage electrical pulses for pancreatic cancer treatment in the era of precision medicine. DOI 10.1097/js9.0000000000003386 ↗
- Paper Nanoadjuvant-Mediated Electro-Immunotherapy Enhances Irreversible Electroporation for Pancreatic Cancer Treatment. DOI 10.1002/adma.202520546 ↗
Lei Xu · 1 shared paper, 2026 · strength 0.32
- Paper High-voltage electrical pulses for pancreatic cancer treatment in the era of precision medicine. DOI 10.1097/js9.0000000000003386 ↗
Wenyuan Ma · 1 shared paper, 2026 · strength 0.32
- Paper High-voltage electrical pulses for pancreatic cancer treatment in the era of precision medicine. DOI 10.1097/js9.0000000000003386 ↗
Xiongbin Lu · 1 shared paper, 2026 · strength 0.26
- Paper Nanoadjuvant-Mediated Electro-Immunotherapy Enhances Irreversible Electroporation for Pancreatic Cancer Treatment. DOI 10.1002/adma.202520546 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.